Not long after the American Medical Association recommended that lawmakers ban direct-to-consumer drug advertising by pharmaceutical manufacturers, Connecticut congresswoman Rosa DeLauro is proposing new curbs in the form of a three-year moratorium on DTC ads for new drugs, as well as a permanent prohibition on ads for drugs determined to have “significant” side effects.
Rosa DeLauro
February 1, 2023
Stay Connected
Subscribe
Events
-
IP Networking State of the Art
16 March 2023
-
Live Production in the Cloud
30 March 2023
- View more events